Treatment for cardiovascular diseases Flashcards

1
Q

treatments for hypertension

A

beta blockers
alpha blockers
diuretics
ACE inhibitors
angiotensin II receptor blockers
Ca2+ channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

beta blockers

A

beta adrenoreceptor (on cardiac smooth muscle) antagonists reduce affects of adrenaline, including: heart rate, cardiac output and renin release
propanolol
atenolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

propanolol
atenolol

A

beta blockers
propanolol = non-selective (beta1 and 2)
atenolol = selective (beta1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

alpha blockers

A

alpha adrenoreceptor (on vessels) blockers reduce affects of adrenaline, including: vasocontriction
phentolamine
doxazosin
prazosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

phentolamine
doxazosin
prazosin

A

alpha blockers
phentolamine = non-selective (alpha1 and 2)
doxazosin, prazosin = selective (alpha1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACE inhibitors

A

reduce blood pressure by reducing angiotensin II conversion, thus aldosterone release. reduces renal reabsorption
captopril
enalapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

captopril
enalapril

A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

angiotensin II receptor blockers

A

AT1 and AT2 receptor antagonists reduce vasoconstriction and aldosterone release
losartan
candesartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

losartan
candesartan

A

AT1 receptor blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

diuretics

A

lowers blood pressure by lowering blood volume through reducing renal reabsorption
bendoflumethazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bendoflumethazide

A

diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ca2+ channel blockers

A

reduce Ca2+ entry into vascular smooth and cardiac muscle by blocking L-type Ca2+ channels
verapamil
diltiazem
nifedipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

verapamil
diltiazem
nifedipine

A

Ca2+ channel blockers
verapamil, diltiazem = open channel blockers
nifedipine = allosteric modulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

selectivity of tissues with
Ca2+ channel blockers

A

cardiac:
- nifedipine
- diltiazem
- verapamil
smooth:
- verapamil
- diltiazem
- nifedipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treatments for angina

A

nitrovasodilators
invabradine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

types of angina

A

stable angina
unstable angina
variant angina

17
Q

nitrovasodilators

A

treats stable angina and used as rapid relief for all types
mimics action of endogenous nitric acid (generally pro-drugs)
GTN
amyl nitrate

18
Q

GTN
amyl nitrate

A

nitrovasodilators used to treat angina

19
Q

invabradine

A

used to treat all forms of angina
blocks Na+ influx into cardiac muscle cells contributing to SA node depolarisation to decrease heart rate but not force

20
Q

treatments used for heart failure

A

dopamine
dobutamine
digoxin (digitalis)
levosimendan (Ca2+ sensitisers)

21
Q

dopamine for heart failure

A

acts on dopamine receptors D1 and D2 in the heart and induces nor-adrenaline release, resulting in vasodilation and increased heart rate

22
Q

dobutamine for heart failure

A

acts on beta1 and beta2 adrenoreceptors in the heart for short-term inotropic support

23
Q

digoxin (digitalis)

A

slows heart rate and provides inotropic support by binding Na+/K+ channels to increase Ca2+ influx and concentration in the heart
- low therapeutic index

24
Q

levosimdenan for heart failure

A

maintains active troponin C conformation to increase heart contractility

25
treatments for atherosclerosis
statins
26
types/stages of atherosclerosis
advanced lesion formation unstable fibrous plaques
27
statins
used to treat atherosclerosis by competitively inhibiting rate-limiting steps in cholesterol synthesis simvastatin pravastatin rosuvastatin
28
simvastatin pravastatin rosuvastatin
statins used to treat atherosclerosis
29
formation of atherosclerosis
1. lesions in vessel allow for entry of blood cells and platelets 2. monocytes/macrophages form lipid-filled foam cells 3. macrophages release MMP enzymes that breakdown structural proteins in the vessel wall 4. advanced lesion formation where fibrous caps form for healing 5. foam cell die leading to lipid oxidation and further monocyte recruitment 6. formation of unstable fibrous plaques where cap thins and may lead to occlusion
30
atherosclerosis risk factors
high cholesterol intake hyperlipidemia hyperlipoproteinaemia
31
hyperlipidemia (hyperlipoproteinaemia)
abnormally high levels of some or all lipids/lipoproteins